Japanese Dermatological Association's Clinical Practice Guidelines for Alopecia Areata 2024: A Complete English Translated Version

IF 2.7 3区医学 Q2 DERMATOLOGY

Journal of Dermatology Pub Date : 2025-07-23 DOI:10.1111/1346-8138.17859

Manabu Ohyama, Taisuke Ito, Yasuyuki Amoh, Shigeki Inui, Hisayoshi Imanishi, Rie Ueki, Masaki Uchiyama, Koya Obara, Misaki Kinoshita-Ise, Teruki Dainichi, Yohei Natsuaki, Ryota Hayashi, Kazutoshi Harada, Masahiro Fukuyama, Masato Mizuashi, Yutaka Shimomura

{"title":"Japanese Dermatological Association's Clinical Practice Guidelines for Alopecia Areata 2024: A Complete English Translated Version","authors":"Manabu Ohyama, Taisuke Ito, Yasuyuki Amoh, Shigeki Inui, Hisayoshi Imanishi, Rie Ueki, Masaki Uchiyama, Koya Obara, Misaki Kinoshita-Ise, Teruki Dainichi, Yohei Natsuaki, Ryota Hayashi, Kazutoshi Harada, Masahiro Fukuyama, Masato Mizuashi, Yutaka Shimomura","doi":"10.1111/1346-8138.17859","DOIUrl":null,"url":null,"abstract":"<p>This is an English-translated version of the Japanese Dermatological Association's clinical practice guidelines for alopecia areata (AA) 2024. It includes the sections of summary, pathogenesis and epidemiology, evaluation and diagnosis, and treatment of AA. Updates based on recent evidence/advances were made in each part. The treatment part contains the statements of recommendation for 25 clinical questions (CQs) with respective recommendation/evidence levels. AA-cube, a graphic illustration conceptualizing the treatment strategy based on individual patients' factors, was newly proposed. Taking into account the recent approval of a JAK inhibitor and a JAK3/TEC family kinase selective inhibitor, a CQ for these modalities was also added. These guidelines aim to support evidence-based management of AA as well as prompt understanding of disease etiopathogenesis.</p>","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"52 10","pages":"e876-e907"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.17859","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.17859","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

This is an English-translated version of the Japanese Dermatological Association's clinical practice guidelines for alopecia areata (AA) 2024. It includes the sections of summary, pathogenesis and epidemiology, evaluation and diagnosis, and treatment of AA. Updates based on recent evidence/advances were made in each part. The treatment part contains the statements of recommendation for 25 clinical questions (CQs) with respective recommendation/evidence levels. AA-cube, a graphic illustration conceptualizing the treatment strategy based on individual patients' factors, was newly proposed. Taking into account the recent approval of a JAK inhibitor and a JAK3/TEC family kinase selective inhibitor, a CQ for these modalities was also added. These guidelines aim to support evidence-based management of AA as well as prompt understanding of disease etiopathogenesis.

Abstract Image

查看原文本刊更多论文

日本皮肤病协会的斑秃临床实践指南2024：完整的英文翻译版本。

这是日本皮肤病协会的斑秃临床实践指南（AA） 2024的英文翻译版本。包括综述、发病与流行病学、评价与诊断、治疗等部分。每个部分都根据最近的证据/进展进行了更新。治疗部分包含25个临床问题（cq）的推荐声明，并给出相应的推荐/证据水平。AA-cube是一种基于患者个体因素的治疗策略概念化的图形说明。考虑到最近批准的一种JAK抑制剂和一种JAK3/TEC家族激酶选择性抑制剂，也增加了这些模式的CQ。这些指南旨在支持AA的循证管理以及对疾病发病机制的及时了解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Dermatology 医学-皮肤病学

CiteScore

4.60

自引率

9.70%

发文量

368

审稿时长

4-8 weeks

期刊介绍： The Journal of Dermatology is the official peer-reviewed publication of the Japanese Dermatological Association and the Asian Dermatological Association. The journal aims to provide a forum for the exchange of information about new and significant research in dermatology and to promote the discipline of dermatology in Japan and throughout the world. Research articles are supplemented by reviews, theoretical articles, special features, commentaries, book reviews and proceedings of workshops and conferences. Preliminary or short reports and letters to the editor of two printed pages or less will be published as soon as possible. Papers in all fields of dermatology will be considered.